News
In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.
Survey probes U.S. adults' willingness to accept COVID-19 vaccine
By Will Boggs MD NEW YORK (Reuters Health) - A national survey that probed U.S. adults' likelihood of accepting a COVID-19 vaccine found efficacy was the most important attribute, with longer
U.S. reports about 300,000 more deaths than usual during pandemic - CDC
By Vishwadha Chander (Reuters) - Nearly 300,000 more people have died in the United States in 2020 during the coronavirus pandemic than expected based on historical trends, with about two-thirds of
CORRECTED-Mexico could absorb some COVID-19 vaccine liabilities
(Corrects headline and paragraph 1 to correct that government to accept some, not all liabilities) By Anthony Esposito and Adriana Barrera MEXICO CITY (Reuters) - Mexico's government could absorb some
Probiotics promising for Parkinson's constipation
By Marilynn Larkin NEW YORK (Reuters Health) - A multi-strain probiotics capsule effectively treated Parkinson's disease (PD)-related constipation in a short-term, single-center, randomized,
COVID-safe classroom strategy includes ventilation, glass screens on each desk
By Linda Carroll (Reuters Health) - A computer model of classroom airflow reveals "multilayer" strategies - including glass screens fastened to the front of desks, open windows, and air conditioning -
Mexico will pay for any COVID-19 vaccine liabilities, government says
By Anthony Esposito and Adriana Barrera MEXICO CITY (Reuters) - Mexico's government will pay to cover any liabilities arising from unexpected side effects of COVID-19 vaccines but is not considering
EXCLUSIVE-AstraZeneca U.S. COVID-19 vaccine trial may resume as soon as this week -sources
By Julie Steenhuysen and Marisa Taylor CHICAGO/WASHINGTON (Reuters) - AstraZeneca Plc's COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and
Dermatitis herpetiformis may be common in patients with celiac disease
By Will Boggs MD NEW YORK (Reuters Health) - As many as 8% of patients with celiac disease (CD) may also have dermatitis herpetiformis (DH), and these patients are less likely to receive counseling on
COVID-19 more severe among some people with congenital heart disease
By Will Boggs MD NEW YORK (Reuters Health) - Patients whose congenital heart disease (CHD) stems from a genetic syndrome or is more physiologically advanced face an increased risk of moderate/severe
U.S. child mortality rates from road traffic accidents vary widely by county
By Lisa Rapaport (Reuters Health) - Across the U.S., disparities persist in child fatalities from road traffic accidents, with higher mortality rates in rural communities and counties without trauma
2,000 calories a day safe, more effective for refeeding anorexic patients
By Anne Harding NEW YORK (Reuters Health) - Higher-calorie refeeding (HCR) is safe and effective in closely monitored anorexia nervosa patients, a new randomized controlled trial shows. Patients who
Trifocal-lens implant frees most from spectacles after cataract surgery
By Anne Harding NEW YORK (Reuters Health) - Patients who receive trifocal-lens implants after cataract surgery are much less likely to need glasses than those who receive monofocal implants, according
Poverty contributes to higher infant mortality in rural areas
By Will Boggs MD NEW YORK (Reuters Health) - Socioeconomic disadvantages are a major contributor to the disparity in infant mortality between rural and nonrural parts of the U.S., and greater
Surgical valve explantation after TAVR tied to high short-term mortality
By David Douglas NEW YORK (Reuters Health) - Surgical valve explantation following successful transcatheter aortic-valve replacement (TAVR) because of factors including structural deterioration is
U.S. FDA meeting on COVID-19 vaccines to discuss criteria for emergency nod
By Reuters Staff (Reuters) - The U.S. health regulator's criteria for allowing emergency use of a COVID-19 vaccine and plans to monitor its safety after a regulatory go-ahead, are among the topics to
UPDATE 1-Most people would get COVID-19 vaccine if offered by government or employer - poll
(Adds link to study) By Josephine Mason LONDON (Reuters) - Most people would get a COVID-19 vaccine if their government or employer recommended it, results of a global poll showed on Tuesday, amid
Cold-chain-independent gel could deliver antibiotics for outer-ear infections with one application
By Scott Baltic NEW YORK (Reuters Health) - Researchers have developed a new single-application drug-delivery system for treating outer-ear infections that does not require refrigeration. A
California says it will independently review coronavirus vaccine
By Mimi Dwyer LOS ANGELES (Reuters) - A California panel of experts will independently review the safety of new coronavirus vaccines and initial plans for distribution, Governor Gavin Newsom said on
UK lab joins global network to compare coronavirus vaccine candidates
By Reuters Staff LONDON (Reuters) - A second British laboratory is joining a global lab network to assess data from potential coronavirus vaccines, set up by a major non-profit health emergencies
Most people would get COVID-19 vaccine if offered by government or employer - poll
By Josephine Mason LONDON (Reuters) - Most people would get a COVID-19 vaccine if their government or employer recommended it, results of a global poll showed on Tuesday, amid growing concerns about
UK plans COVID-19 'challenge' trials that deliberately infect volunteers
By Kate Kelland LONDON (Reuters) - Britain will help to fund trials using a manufactured COVID-19 virus to deliberately infect young healthy volunteers with the hope of accelerating the development of
REFILE-Study challenges idea that children are asymptomatic COVID-19 spreaders
(Corrects spelling of "Ospedale" in para 2, in story originally posted Sept 14.) By Megan Brooks NEW YORK (Reuters Health) - A study from Italy does not support the theory that children are more
REFILE-EXCLUSIVE-Study suggests dengue may provide some immunity against COVID-19
(Fixes coding on 9-21 story with no changes to text, to address formatting errors seen by some clients.) By Pedro Fonseca RIO DE JANEIRO (Reuters) - A new study that analyzed the coronavirus outbreak
Limited parental English proficiency tied to adverse events in pediatric patients
By Lisa Rapaport (Reuters Health) - Hospitalized children are more likely to experience adverse events when their parents have limited English proficiency or don't feel comfortable speaking English, a
UPDATE 2-Trump calls Fauci a 'disaster' and seeks to reassure his team he can win
((Updates with Lamar Alexander reaction, note language in paragraph 16) By Jeff Mason and Steve Holland LAS VEGAS/WASHINGTON (Reuters) - President Donald Trump called coronavirus expert Anthony Fauci
Linked color imaging bests conventional imaging for upper GI cancer detection
By Marilynn Larkin NEW YORK (Reuters Health) - Linked color imaging (LCI), an image-enhanced endoscopy technique that enables users to recognize slight differences in mucosal color, was more effective
Per-oral endoscopic myotomy "reasonable" first-line treatment for idiopathic achalasia
By Marilynn Larkin NEW YORK (Reuters Health) - Per-oral endoscopic myotomy (POEM) has comparable efficacy to laparoscopic Heller's myotomy (LHM) for the treatment of achalasia, and was ranked first in
Europe, North America should learn from Asia on COVID-19 - WHO expert
By Stephanie Nebehay and Michael Shields GENEVA (Reuters) - Europe and North America should follow the example of Asian states by persevering with anti-COVID measures and quarantining anyone who comes
Noninvasive ventilation rare, but becoming more common at end of life
By Lisa Rapaport (Reuters Health) - A growing number of Medicare beneficiaries are receiving noninvasive mechanical ventilation instead of invasive mechanical ventilation at the end of life,
All-female scientific coalition calls for protection of Antarctic Peninsula
By Cassandra Garrison BUENOS AIRES (Reuters) - Climate change and human activity are harming Antarctica and threatening wildlife from humpback whales to microscopic algae, more than 280 scientists and
Biofeedback does not improve pelvic floor muscle training effect for urinary incontinence
By Linda Carroll (Reuters Health) - While pelvic floor muscle training can improve symptoms of urinary incontinence, there is no benefit to adding eletromyographic biofeedback, a new study suggests.
Sanctuary policies result in fewer deportations without increasing crime
By Linda Carroll (Reuters Health) - Local sanctuary policies lead to fewer deportations of noncitizens with no increases in crime, a new U.S. study suggests. In an analysis of data on Immigration and
Image-guided biopsy may help some avoid breast-cancer surgery
By David Douglas NEW YORK (Reuters Health) - Following neoadjuvant chemotherapy, image-guided vacuum-assisted biopsy (VAB) can reliably identify a subgroup of patients with no residual disease in the
RPT-Most cancer patients would join a clinical trial if offered the chance
(Repeats to additional subscribers with no change to text) By Anne Harding NEW YORK (Reuters Health) - New findings debunk the conventional wisdom that Black cancer patients are less likely to agree
Coronavirus vaccine unlikely to be available in Britain before spring - adviser
By Reuters Staff LONDON (Reuters) - It is unlikely a coronavirus vaccine will be in widespread use in Britain before next spring, the government's chief scientific adviser Patrick Vallance said on
COVID-19 outcomes vary widely in patients with primary immunodeficiencies
By Will Boggs MD NEW YORK (Reuters Health) - Clinical outcomes of COVID-19 in patients with primary immunodeficiency diseases range from mild illness to death, according to a small case series. "We
Most cancer patients would join a clinical trial if offered the chance
By Anne Harding NEW YORK (Reuters Health) - New findings debunk the conventional wisdom that Black cancer patients are less likely to agree to participate in clinical trials. Overall, 55% of patients
Polish woman's quest for abortion exposes conflicted society
By Alicja Ptak WARSAW (Reuters) - In April, in the midst of a nationwide coronavirus lockdown in Poland, Katarzyna found out that the baby she was carrying had a severe genetic disorder and would
UPDATE 1-Trump calls Fauci a 'disaster' and seeks to reassure his team he can win
(Updates with more details of call) By Jeff Mason and Steve Holland LAS VEGAS/WASHINGTON (Reuters) - U.S. President Donald Trump called coronavirus expert Anthony Fauci a "disaster" on Monday and
Trump blasts Fauci, seeks to reassure his team he has pathway to win
By Jeff Mason and Steve Holland LAS VEGAS/WASHINGTON (Reuters) - U.S. President Donald Trump blasted coronavirus expert Anthony Fauci as a "disaster" on Monday in a conference call with campaign
Gene signature predicts overall survival in women with breast cancer
By Reuters Staff NEW YORK (Reuters Health) - A prognostic signature based on eight DNA-repair-related genes (DRGs) accurately predicts overall survival in women with breast cancer, researchers report.
Genetic variations linked to post-partum hemorrhage
By Rob Goodier NEW YORK (Reuters Health) - Researchers have discovered several genetic variations associated with a greater risk for post-partum hemorrhage. The affected genes appear to be involved in
Cardiovascular, kidney benefits consistent across SGLT2 inhibitors
By Reuters Staff NEW YORK (Reuters Health) - Sodium-glucose transporter 2 (SGLT2) inhibitors lower the risk of major adverse cardiovascular (CV) outcomes in people with type-2 diabetes, according to a
Two SARS-CoV-2 antibody assays perform best
By Will Boggs MD NEW YORK (Reuters Health) - Among four high-throughput assays for detecting antibodies against SARS-CoV-2 in patient samples, those from Roche and Siemens provide superior sensitivity
ICUs without air-conditioning could shield doctors from COVID-19 - study
By Anuron Kumar Mitra BENGALURU (Reuters) - Intensive care units (ICUs) at hospitals treating COVID-19 patients should do away with air-conditioning to limit the risk of infecting doctors, a study
INSIGHT-Doctors probe whether COVID-19 is causing diabetes
By Chad Terhune (Reuters) - Mario Buelna, a healthy 28-year-old father, caught a fever and started having trouble breathing in June. He soon tested positive for COVID-19. Weeks later, after what had
Twitter raps Trump COVID-19 adviser as U.S. cases rise
By Doina Chiacu WASHINGTON (Reuters) - Twitter on Sunday removed a "misleading" tweet downplaying the efficacy of masks posted by a top coronavirus adviser to President Donald Trump, while U.S. cases
'Bad math': Airlines' COVID safety analysis challenged by expert
By Laurence Frost PARIS (Reuters) - A campaign by coronavirus-stricken aviation giants to persuade the world it's safe to fly has been questioned by one of the scientists whose research it draws upon.
Hospitalised COVID-19 patients can have ongoing symptoms for months -study
By Reuters Staff LONDON (Reuters) - More than half of COVID-19 patients discharged from hospital still experienced symptoms of breathlessness, fatigue, anxiety and depression for two to three months
One therapy to combat three deadly coronaviruses?
By Reuters Staff (Reuters) - The viruses that cause COVID-19, SARS and MERS have common mechanisms that might be promising targets for a treatment that would work against all three, plus future
COVID-19 rare among U.S. dentists: survey
By Reuters Staff (Reuters) - Less than 1% of U.S. dentists have tested positive for COVID-19, even though dental procedures generate aerosols that may contain particles of the new coronavirus,
Pandemic beliefs, behaviors may be gender-based
By Reuters Staff (Reuters) - Women are more likely than men to consider COVID-19 a serious problem and to agree and comply with restrictions like staying home and wearing masks, survey data suggest.
TAVR likely beneficial in low-risk patients with bicuspid valve stenosis
By Marilynn Larkin NEW YORK (Reuters Health) - Low-surgical risk patients with bicuspid aortic valve stenosis experienced favorable 30-day results with transcatheter aortic valve replacement (TAVR) in
Music training tied to improved attention and working memory in kids
By Lisa Rapaport Oct 16 () - (Reuters Health) - Children who regularly practice a musical instrument may have better attention and working memory than kids who don't, data from functional MRI studies
Carpal tunnel decompression surgery has few serious complications
By Lisa Rapaport (Reuters Health) - Carpal tunnel decompression surgery rarely results in serious complications or reoperations, a U.K. study suggests. Researchers examined data on 855,832 carpal
Transgender youth supportive of telehealth for ongoing gender care
By Lisa Rapaport (Reuters Health) - Many transgender youth are open to receiving gender-affirming care via telehealth, and a new study also suggests that this approach may be preferable for ongoing
Median ALS survival extended 44%, to 25.0 months, by experimental drug
By Reuters Staff (Reuters Health) - Additional results from the phase 2 CENTAUR study on patients with amyotrophic lateral sclerosis (ALS) show that the experimental Amylyx Pharmaceuticals drug
Immediate surgery best in pregnant women with complicated appendicitis
By Megan Brooks NEW YORK (Reuters Health) - For pregnant women with complicated appendicitis, immediate surgery yields significantly better maternal and fetal outcomes than medical management,
CVS, Walgreens to administer COVID-19 vaccines to U.S. nursing homes - HHS
By Reuters Staff (Reuters) - The U.S. government has signed agreements with pharmacy chains CVS Health Corp and Walgreens Boot Alliance to administer COVID-19 vaccines to residents of long-term care
'Not fake news:' COVID-19 cases surge in Wisconsin ahead of Trump campaign rally
By Brendan O'Brien and Maria Caspani CHICAGO (Reuters) - Two weeks ago, Mark Schultz was getting ready to go to work at the tavern he owns in the Wisconsin city of Oshkosh when he started to feel
Telemedicine could help rural patients with dementia
By Carolyn Crist NEW YORK (Reuters Health) - Older adults with dementia require ongoing access to healthcare services, and telemedicine could be a good option to bridge that gap during the pandemic,
Two-vaccine regimen yields best antibody response to Ebola
By Will Boggs MD NEW YORK (Reuters Health) - Sequential administration of two different Ebola vaccines spaced several weeks apart yields the best antibody responses, according to an early trial. Dr.
Diagnosing Hodgkin lymphoma in kids requires biopsy, immunohistochemistry: guidelines
By Will Boggs MD NEW YORK (Reuters Health) - The diagnosis of pediatric Hodgkin lymphoma requires an excisional or incisional biopsy and immunohistochemistry (IHC) evaluation, and its management
Invasive features, positive margins tied to worse outcome of precancerous pancreas lesions
By Will Boggs MD NEW YORK (Reuters Health) - Invasive pathology and positive surgical margins are associated with worse outcomes after resection of intraductal papillary mucinous neoplasms (IPMNs) of
Bone health could be impaired 25 years later in extreme preemies
By Scott Baltic NEW YORK (Reuters Health) - Young adults who were born extremely preterm or with extremely low birthweight (EP/ELBW) may have impaired bone health many years later, compared with their
Long-acting HIV injection gets EU panel endorsement
By Reuters Staff (Reuters) - GlaxoSmithKline Plc said an injection of its cabotegravir drug given every two months, in combination with Johnson & Johnson's rilpivirine, was recommended for approval to
NIH tests therapies to help cut hospital stays for COVID-19 patients
By Reuters Staff (Reuters) - The U.S. National Institutes of Health (NIH) has started a late-stage trial to evaluate if immune-modulating therapies from three drugmakers can help reduce the need for
EU medicine agency could approve COVID-19 vaccines early next year - report
By Reuters Staff MILAN (Reuters) - The European Medicines Agency could approve three COVID-19 vaccines early next year, its Executive Director Guido Rasi said on Friday, according to a report by
Pfizer says earliest COVID-19 vaccine application to U.S. regulators would be after election
By Manas Mishra and Michael Erman (Reuters) Pfizer Inc said on Friday it may file for U.S. authorization of the COVID-19 vaccine it is developing with German partner BioNTech in late November, making
Urologists offer more options for treating erectile dysfunction
By Will Boggs MD NEW YORK (Reuters Health) - Urologists and non-urologists differ in their management of men with erectile dysfunction (ED), according to survey data from the U.S. "While oral
Cannabis use tied to increased odds of non-medical opioid use
By Lisa Rapaport (Reuters Health) - Adults with substance use problems may be more likely to misuse opioids on days when they use cannabis, a study in New York suggests. Researchers examined data from
For some, anti-VEFG treatment preserves sight for a lifetime
By Linda Carroll (Reuters Health) - Nearly 20% of those who received anti-VEGF treatment for neovascular age-related macular degeneration (nAMD) retained useful visual acuity over their lifetime, a
Aerosolized surfactant shows promise for newborns with respiratory distress
By Reuters Staff NEW YORK (Reuters Health) - Delivery of aerosolized calfactant, a type of surfactant, reduced the need for intubation for liquid surfactant by nearly 50% in a large randomized
WHO study says remdesivir did not reduce mortality in COVID-19 patients - FT
By Reuters Staff (Reuters) - Gilead Sciences Inc's remdesivir had no substantial effect on COVID-19 patients' chances of survival, a clinical trial by the World Health Organization (WHO) has found,
In U.S. Midwest states, new COVID-19 infections rise to record highs
By Lisa Shumaker and Maria Caspani CHICAGO (Reuters) - Wisconsin and other states in the U.S. Midwest are battling a surge in COVID-19 cases, with new infections and hospitalizations rising to record
Spain adds 13,300 COVID infections, Catalonia to shut bars, eateries
By Reuters Staff MADRID (Reuters) - Spain's cumulative tally of coronavirus infections rose by over 13,300 on Thursday to 921,374 in a slight acceleration from the previous few days, as the region of
France's new COVID-19 cases set new 24-hour record, above 30,000
By Reuters Staff PARIS (Reuters) - French health authorities on Thursday reported the number of new daily coronavirus infections jumped above 30,000 for the first time since the start of the epidemic.
Coronavirus exposure risk on airplanes very low, U.S. defense study finds
By Reuters Staff (Reuters) - The risk of exposure to the coronavirus on flights is very low, a U.S. Department of Defense study released on Thursday found, a positive sign for the airline industry as
Starting in November, U.S. patients will have open access to clinical notes
By Carolyn Crist (Reuters Health) - Starting November 2, new federal rules will allow U.S. patients to view their electronic health records, including notes written by doctors and health care
Blood chloroform levels in late pregnancy tied to higher risk of SGA newborns
By Marilynn Larkin NEW YORK (Reuters Health) - Chloroform (trichloromethane; TCM) exposure in late pregnancy from drinking water and other disinfection byproducts (DBPs) was associated with a higher
XY gonadal dysgenesis unexpectedly identified by direct-to-consumer genetic testing
By Will Boggs MD NEW YORK (Reuters Health) - A 16-year-old female was unexpectedly identified by direct-to-consumer (DTC) genetic testing to have XY gonadal dysgenesis and subsequently diagnosed with
Percutaneous gallstone removal may be an option in high-risk symptomatic patients
By Marilynn Larkin NEW YORK (Reuters Health) - For patients with acute cholecystitis who are not candidates for surgery, cholecystostomy tube insertion followed by percutaneous cholecystolithotomy (
Telemedicine for pain management may save patients' time and money
By Rob Goodier NEW YORK (Reuters Health) - Virtual pain medicine visits, rather than in-person office visits, saved patients an average of more than two hours in driving time and more than $100 in
Icotinib plus radiotherapy ups survival in elderly with esophageal cancer
By David Douglas NEW YORK (Reuters Health) - Icotinib with concurrent radiotherapy (RT) boosts survival and may have other benefits compared to RT alone in elderly patients with unresectable
Sanofi reports positive animal test results for potential COVID-19 vaccine
By Matthias Blamont PARIS (Reuters) - Clinical trials of an experimental vaccine against COVID-19 which is being developed by France's Sanofi and U.S. biotech firm Translate Bio are on track to begin
WHO vaccine drive bedevilled by familiar question: who pays if things go wrong?
By Francesco Guarascio BRUSSELS (Reuters) - Who foots the bill if people in poor countries fall sick with unexpected side-effects from coronavirus vaccines? It's not clear and that's a big problem in
REFILE-Mental health services disrupted during pandemic, as needs grow - WHO
(Adds link to source material for Oct 5 article, at end of story.) By Reuters Staff GENEVA (Reuters) - Services for mentally ill and substance abuse patients have been disrupted worldwide during the
Young women have worse MI outcomes than men of same age
By Linda Carroll (Reuters Health) - Long term mortality is higher in women than in men who have a myocardial infarction (MI) at a young age, a new study finds. The review of data on more than 2,000
Software predicts which patients may need more post-op opioids
By Rob Goodier NEW YORK (Reuters Health) - Three newly tested software models can mine patients' medical records to predict who may be in greater need of opioid pain medication after surgery,
COVID-19 neurological effects may reflect immune response
By Reuters Staff (Reuters) - The new coronavirus might not be having major direct effects on the brain despite neurological issues that have been widely reported, a new paper suggests. Researchers
Common cold antibodies do not protect against COVID-19
By Reuters Staff (Reuters) - Antibodies that recognize and fight off the coronaviruses that cause common colds are not likely to protect against the coronavirus that causes COVID-19, new research
Regeneron's drug becomes first FDA-approved Ebola virus treatment
By Deena Beasley (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Regeneron Pharmaceuticals' triple antibody cocktail as the first Ebola treatment, lending validation to similar
Motivational interviews with parents help them support kids' weight management
By Lisa Rapaport (Reuters Health) - Motivational interviews with parents appears to help them promote healthy habits in children, a systematic review suggests. "Some more traditional approaches of
New coronavirus rapid diagnostic tests will be game changer -PAHO director
By Anthony Esposito and Adriana Barrera MEXICO CITY (Reuters) - Rapid antigen diagnostic tests for the novel coronavirus will be a game changer in the fight against the pandemic, the Pan American
Curfews and lockdowns as shaken Europe overtakes U.S. in virus surge
By Benoit Van Overstraeten and Jan Lopatka PARIS/PRAGUE (Reuters) - France imposed curfews while other European nations are closing schools, cancelling surgeries and enlisting student medics as
Bariatric surgery increases life expectancy in large Swedish study
By Gene Emery (Reuters Health) - Bariatric surgery gives severely-obese patients an average of three extra years of life, although the operation does not bring the risk of early death down to the same
Upadacitinib superior to abatacept for arthritis but sparks more side effects
By Gene Emery (Reuters Health) - A 24-week phase 3 trial of AbbVie's upadacitinib shows that it produces more remissions and a better score on a rheumatoid arthritis (RA) scale than conventional
Hospitalized US children often exposed to drug-drug interactions
By Lisa Rapaport (Reuters Health) - Proportions of hospitalized U.S. children who are exposed to potentially serious drug-drug interactions vary widely, and the risk is increased with longer stays and
Double-targeted CAR-T cell immunotherapy promising for refractory non-Hodgkin lymphoma
By Marilynn Larkin NEW YORK (Reuters Health) - A novel chimeric antigen receptor (CAR)-T cell therapy for refractory B-cell non-Hodgkin lymphoma that targets both CD19 and CD20 antigens was safe and
'STOP THE BLEED' saving lives across the globe
By Megan Brooks NEW YORK (Reuters Health) - The American College of Surgeons (ACS) STOP THE BLEED training program is saving lives around the world, according to two studies presented October 3 at the
